Cardio Diagnostics Holdings (CDIO) Intangibles (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Intangibles of $929586.0 for Q1 2026, up 6.46% sequentially from $873182.0 in Q4 2025, and up 32.56% YoY from $701279.0 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Intangibles (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Intangibles for 6 years, with the latest figure at $929586.0 in Q1 2026.
- Quarterly Intangibles rose 32.56% year-over-year to $929586.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $929586.0 (up 32.56% YoY) and the FY2025 annual result came in at $873182.0, up 16273.19% from the prior year.
- Intangibles rose to $929586.0 in Q1 2026 per CDIO's latest filing, from $873182.0 in the prior quarter.
- Over five years, Intangibles peaked at $929586.0 in Q1 2026 and troughed at $5333.0 in Q4 2024.
- A 5-year average of $341607.5 and a median of $200654.0 in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2025: Intangibles plunged 98.08% in 2024, then jumped 16273.19% in 2025.
- Over 5 years, Intangibles stood at $321308.0 in 2022, then slumped by 93.36% to $21333.0 in 2023, then plunged by 75.0% to $5333.0 in 2024, then surged by 16273.19% to $873182.0 in 2025, then advanced by 6.46% to $929586.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $929586.0, $873182.0, and $80000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cardio Diagnostics Holdings | 6.05 Mn | 460,682.10 | - | 970,782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 970,782.00 |
| Mar 31, 2026 | 929,586.00 |
| Dec 31, 2025 | 873,182.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 701,279.00 |
| Dec 31, 2024 | 5,333.00 |
| Sep 30, 2024 | 9,333.00 |
| Jun 30, 2024 | 596,944.00 |
| Mar 31, 2024 | 564,565.00 |
| Dec 31, 2023 | 21,333.00 |
| Sep 30, 2023 | 486,309.00 |
| Jun 30, 2023 | 80,000.00 |
| Mar 31, 2023 | 33,333.00 |
| Dec 31, 2022 | 321,308.00 |
| Dec 31, 2021 | 245,154.00 |